Result of Special Meeting

 

TIDMRPSE 
 
RNS Number : 0563Y 
Research Pharmaceutical SRV, Inc 
26 August 2009 
 

August 26, 2009 
 
 
ReSearch Pharmaceutical Services, Inc. 
Result of Special Meeting of Stockholders and Warrantholders 
 
 
Further to the announcement issued on July 27, 2009, ReSearch Pharmaceutical 
Services, Inc. (the "Company") announces that at the Special Meeting of 
stockholders and warrantholders held earlier today, Proposal One, which related 
to stockholder approval of cancellation of the Company's common stock (the 
"Common Stock") from trading on AIM, was passed by the requisite majority. 
Proposal One-W which related to warrant holder approval of cancellation of the 
Company's warrants (the "Warrants") from trading on AIM was not passed. 
Consequently, it is anticipated that admission to trading on AIM of the Common 
Stock will be cancelled from 7.00 am on September 4, 2009 following which the 
Common Stock will not be tradeable on AIM, but will remain transferable as 
described in the proxy statement mailed to stockholders and warrant holders on 
July 24, 2009 and subject to applicable securities laws. 
The Company's nominated adviser has indicated that it will resign from its 
position as nominated adviser as of the date the Common Stock is cancelled from 
trading on AIM.  Thereafter, trading of the Warrants on AIM will be suspended, 
and if the Company does not appoint another nominated adviser within one month 
after the suspension from trading on AIM of the Warrants (which appointment of a 
new nominated adviser the Company believes to be unlikely), the admission of the 
Warrants to trading on AIM  will  also be cancelled. 
 
 
For further information please contact: 
 
 
ReSearch Pharmaceutical Services, Inc.:                                 +1 215 
540 0700 
Daniel M. Perlman, Chairman & Chief Executive Officer 
Steven Bell, Chief Financial Officer 
 
 
Nominated Adviser and UK Broker:                                       +44 20 
7012 2000 
Arbuthnot Securities Limited 
James Steel / Ed Burbidge 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 ROMPFMITMMTTBAL